BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 3, 2026
See today's BioWorld
Home
» Kite lands in Asia, inks CAR-T deals with Fosun, Daiichi Sankyo
To read the full story,
subscribe
or
sign in
.
Kite lands in Asia, inks CAR-T deals with Fosun, Daiichi Sankyo
Jan. 13, 2017
By
Shannon Ellis
SHANGHAI – High-flying CAR-T developer, Kite Pharma Inc., of Santa Monica, Calif., is making a push into China and Japan.
BioWorld